These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36100144)

  • 61. Evolution of carbapenemase-producing Enterobacteriaceae at the global and national level: what should be expected in the future?
    Oteo J; Miró E; Pérez-Vázquez M; Navarro F
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():17-23. PubMed ID: 25542048
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The influence of hospital antimicrobial use on carbapenem-non-susceptible Enterobacterales incidence rates according to their mechanism of resistance: a time-series analysis.
    Ortiz-Brizuela E; Caro-Vega Y; Bobadilla-Del-Valle M; Leal-Vega F; Criollo-Mora E; López Luis BA; Esteban-Kenel V; Torres-Veintimilla E; Galindo-Fraga A; Olivas-Martínez A; Tovar-Calderón E; Torres-González P; Sifuentes-Osornio J; Ponce-de-León A
    J Hosp Infect; 2020 Aug; 105(4):757-765. PubMed ID: 32565368
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prevalence and Characteristics of Extended-Spectrum-β-Lactamase-Producing and Carbapenemase-Producing
    Sapugahawatte DN; Li C; Zhu C; Dharmaratne P; Wong KT; Lo N; Ip M
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32295872
    [TBL] [Abstract][Full Text] [Related]  

  • 64. In vivo study assessed meropenem and amikacin combination therapy against carbapenem-resistant and carbapenemase-producing Enterobacteriaceae strains.
    Hagihara M; Kato H; Yamashita R; Soda M; Watanabe H; Sakanashi D; Shiota A; Asai N; Koizumi Y; Suematsu H; Yamagishi Y; Kitaichi K; Mikamo H
    J Infect Chemother; 2020 Jan; 26(1):1-7. PubMed ID: 31735629
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treating infections caused by carbapenemase-producing Enterobacteriaceae.
    Tzouvelekis LS; Markogiannakis A; Piperaki E; Souli M; Daikos GL
    Clin Microbiol Infect; 2014 Sep; 20(9):862-72. PubMed ID: 24890393
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nitro-Carba test, a novel and simple chromogenic phenotypic method for rapid screening of carbapenemase-producing Enterobacteriaceae.
    Teethaisong Y; Nakouti I; Evans K; Eumkeb G; Hobbs G
    J Glob Antimicrob Resist; 2019 Sep; 18():22-25. PubMed ID: 30668995
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Epidemiology of carbapenemase-producing Enterobacteriaceae in a pediatric hospital in a country with high endemicity.
    Castagnola E; Tatarelli P; Mesini A; Baldelli I; La Masa D; Biassoni R; Bandettini R
    J Infect Public Health; 2019; 12(2):270-274. PubMed ID: 30477920
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Successful treatment of invasive carbapenemase-producing Enterobacteriaceae infections in children using carbapenem-aminoglycoside combination therapy: A case series.
    Williams PCM; Bartlett AW; Palasanthiran P; Armstrong B; McMullan BJ
    Infect Dis Health; 2020 Nov; 25(4):314-318. PubMed ID: 32698988
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Assessing the in vitro activity of ceftazidime/avibactam and aztreonam among carbapenemase-producing Enterobacteriaceae: Defining the zone of hope.
    Avery LM; Nicolau DP
    Int J Antimicrob Agents; 2018 Nov; 52(5):688-691. PubMed ID: 30044946
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Blood-Modified Carbapenem Inactivation Method: a Phenotypic Method for Detecting Carbapenemase-Producing
    Sfeir MM; Satlin MJ; Fauntleroy KA; Jenkins SG; Westblade LF
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31748319
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital.
    Yan L; Sun J; Xu X; Huang S
    Antimicrob Resist Infect Control; 2020 Sep; 9(1):155. PubMed ID: 32967718
    [TBL] [Abstract][Full Text] [Related]  

  • 72. An agar plate-based modified carbapenem inactivation method (p-mCIM) for detection of carbapenemase-producing Enterobacteriaceae.
    Byun JH; Seo Y; Kim D; Kim M; Lee H; Yong D; Lee K; Chong Y
    J Microbiol Methods; 2020 Jan; 168():105781. PubMed ID: 31756348
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Case series of carbapenemase-producing Enterobacteriaceae osteomyelitis: Feel it in your bones.
    Davido B; Noussair L; Saleh-Mghir A; Salomon E; Bouchand F; Matt M; Lawrence C; Bauer T; Herrmann JL; Perronne C; Gaillard JL; Rottman M; Dinh A
    J Glob Antimicrob Resist; 2020 Dec; 23():74-78. PubMed ID: 32882450
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Managing All the Genotypic Knowledge: Approach to a Septic Patient Colonized by Different
    Park SC; Wailan AM; Barry KE; Vegesana K; Carroll J; Mathers AJ; Miller WR; Munita JM
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31345843
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.
    Rodríguez-Baño J; Gutiérrez-Gutiérrez B; Machuca I; Pascual A
    Clin Microbiol Rev; 2018 Apr; 31(2):. PubMed ID: 29444952
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].
    Stock I
    Med Monatsschr Pharm; 2014 May; 37(5):162-72; quiz 173-4. PubMed ID: 24908928
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Modified Hodge test using Mueller-Hinton agar supplemented with cloxacillin improves screening for carbapenemase-producing clinical isolates of Enterobacteriaceae.
    Takayama Y; Adachi Y; Nihonyanagi S; Okamoto R
    J Med Microbiol; 2015 Jul; 64(7):774-777. PubMed ID: 25934552
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clearance Rate of Carbapenemase-Producing Enterobacteriaceae Carriage Among Hospitalized Patients.
    Kim KR; Lee JY; Park HY; Kwak SH; Lim YJ; Hong MJ; Kim SK; Park SY; Kim HJ; Choi HS; Kim MN; Choi HR; Jeong JS; Choi SH
    Infect Control Hosp Epidemiol; 2015 Nov; 36(11):1361-2. PubMed ID: 26174417
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla
    Solgi H; Badmasti F; Aminzadeh Z; Giske CG; Pourahmad M; Vaziri F; Havaei SA; Shahcheraghi F
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2127-2135. PubMed ID: 28639165
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Molecular and epidemiological characterization of IMP-type metallo-β-lactamase-producing Enterobacter cloacae in a Large tertiary care hospital in Japan.
    Hayakawa K; Miyoshi-Akiyama T; Kirikae T; Nagamatsu M; Shimada K; Mezaki K; Sugiki Y; Kuroda E; Kubota S; Takeshita N; Kutsuna S; Tojo M; Ohmagari N
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3441-50. PubMed ID: 24709261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.